Young female professional dancers and other young female athletes both face the same health risks when they don't eat enough to replace the calories they expend, and stop menstruating as a consequence, according to new research from The Medical College of Wisconsin.
"These two components of the female athlete tetrad put them at higher risk for the other two; the cardiovascular and bone density deficits of much older, postmenopausal women," says lead researcher Dr. Anne Hoch, associate professor of orthopaedic surgery.
Two blood proteins blood that could become important markers for long-term breast cancer survival have been identified by research out of Fred Hutchinson Cancer Research Center (FHCRC)1. The proteins, C-reactive protein (CRP) and serum amyloid A (SAA), are linked with chronic inflammation, known to contribute to cancer development and progression, according to the study in the May 18 2009 edition of the Journal of Clinical Oncology.
Two people have the same genetic disease. One of them goes blind in childhood, the other much later in life. It is a phenomenon that has intrigued researchers for years, and is a focus of the field of epigenetics, the study of changes in gene expression caused by mechanisms other than changes in the underlying DNA sequence.
Researchers at Wake Forest University School of Medicine have uncovered something that may help explain how people not genetically predisposed to epilepsy develop the disorder.
Published in the Journal of Neuroscience, the study(1) reports that a gene known to predispose people who inherit an active form of it to certain forms of epilepsy, can be "switched on" in mice that do not appear to have inherited the active form, and thus a genetic predisposition, to the condition.
Aging patients confined to wheelchairs by non-healing fractures were able to walk and live independently again following treatment with the osteoporosis drug teriparatide (Forteo), a preliminary study has found. Research presented in February at the Orthopaedic Research Society meeting showed that out of 145 patients who had an unhealed bone fracture, half of them for six months or longer, 93 percent showed significant healing and pain control after being on teriparatide, a recombinant form of parathyroid hormone, for only eight to 12 weeks.